4//SEC Filing
JENSEN JESSICA D. 4
Accession 0001104659-22-042619
CIK 0001811764other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 10:48 AM ET
Size
5.4 KB
Accession
0001104659-22-042619
Insider Transaction Report
Form 4
JENSEN JESSICA D.
EVP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+13,766→ 13,766 totalExercise: $7.91Exp: 2028-04-01→ Common Stock (13,766 underlying)
Footnotes (1)
- [F1]The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868742
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 10:48 AM ET
- Size
- 5.4 KB